138 related articles for article (PubMed ID: 19346661)
1. Impact of decreased renal function on coagulation and fibrinolysis in patients with non-valvular atrial fibrillation.
Tanaka H; Sonoda M; Kashima K; Tanaka Y; Nakamura K; Nuruki N; Tsubouchi H
Circ J; 2009 May; 73(5):846-50. PubMed ID: 19346661
[TBL] [Abstract][Full Text] [Related]
2. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation.
Matsumoto M; Sakaguchi M; Okazaki S; Furukado S; Tagaya M; Etani H; Shimazu T; Yoshimine T; Mochizuki H; Kitagawa K
Cerebrovasc Dis; 2013; 35(1):64-72. PubMed ID: 23428999
[TBL] [Abstract][Full Text] [Related]
3. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
4. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
5. Imbalance of coagulation and fibrinolysis can predict vascular access failure in patients on hemodialysis after vascular access intervention.
Hasuike Y; Kakita N; Aichi M; Masachika S; Kantou M; Ikeda Takahashi S; Nanami M; Nagasawa Y; Kuragano T; Nakanishi T
J Vasc Surg; 2019 Jan; 69(1):174-180.e2. PubMed ID: 29914835
[TBL] [Abstract][Full Text] [Related]
6. Serum D-dimer Levels Are Proportionally Associated with Left Atrial Enlargement in Patients with an Acute Ischemic Stroke due to Non-valvular Atrial Fibrillation.
Kim TW; Song IU; Chung SW; Kim JS; Koo J; Lee KS
Intern Med; 2016; 55(11):1447-52. PubMed ID: 27250050
[TBL] [Abstract][Full Text] [Related]
7. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
8. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
[TBL] [Abstract][Full Text] [Related]
9. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
[TBL] [Abstract][Full Text] [Related]
10. Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation.
Nozawa T; Inoue H; Iwasa A; Okumura K; Jong-dae L; Shimizu A; Hayano M; Yano K
Circ J; 2004 Jan; 68(1):29-34. PubMed ID: 14695462
[TBL] [Abstract][Full Text] [Related]
11. Activation of the endogenous coagulation system in patients with atrial flutter: relationship to echocardiographic markers of thromboembolic risk.
Kamath GS; Herweg B; Cotiga D; Pierce W; Cohen AJ; Chaudhry FA; Drejka ML; Steinberg JS
Cardiol J; 2010; 17(4):390-6. PubMed ID: 20690096
[TBL] [Abstract][Full Text] [Related]
12. Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.
Tóth NK; Csanádi Z; Hajas O; Kiss A; Nagy-Baló E; Kovács KB; Sarkady F; Muszbek L; Bereczky Z; Csiba L; Bagoly Z
Biomed Res Int; 2017; 2017():3678017. PubMed ID: 28713823
[TBL] [Abstract][Full Text] [Related]
13. Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism.
Inoue H; Nozawa T; Okumura K; Jong-Dae L; Shimizu A; Yano K
Chest; 2004 Sep; 126(3):687-92. PubMed ID: 15364743
[TBL] [Abstract][Full Text] [Related]
14. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation.
Heppell RM; Berkin KE; McLenachan JM; Davies JA
Heart; 1997 May; 77(5):407-11. PubMed ID: 9196408
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics/Pharmacodynamics of Dabigatran 75 mg Twice Daily in Patients With Nonvalvular Atrial Fibrillation and Severely Impaired Renal Function.
Martin JL; Esmaeili H; Manuel RC; Petrini M; Wiebe S; Maas H
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):399-406. PubMed ID: 29695165
[TBL] [Abstract][Full Text] [Related]
16. Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state.
Igarashi Y; Kashimura K; Makiyama Y; Sato T; Ojima K; Aizawa Y
Jpn Circ J; 2001 Sep; 65(9):788-92. PubMed ID: 11548877
[TBL] [Abstract][Full Text] [Related]
17. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia.
Yamanaka A; Kimura F; Yoshida T; Kita N; Takahashi K; Kushima R; Murakmai T
Eur J Obstet Gynecol Reprod Biol; 2016 Sep; 204():99-103. PubMed ID: 27543913
[TBL] [Abstract][Full Text] [Related]
18. A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with hunt-hess grade and outcome.
Nina P; Schisano G; Chiappetta F; Luisa Papa M; Maddaloni E; Brunori A; Capasso F; Corpetti MG; Demurtas F
Surg Neurol; 2001 Apr; 55(4):197-203. PubMed ID: 11358585
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GYH
Chest; 2014 Jun; 145(6):1370-1382. PubMed ID: 24356875
[TBL] [Abstract][Full Text] [Related]
20. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state.
Ariëns RA; de Lange M; Snieder H; Boothby M; Spector TD; Grant PJ
Lancet; 2002 Feb; 359(9307):667-71. PubMed ID: 11879863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
